More on ADORA.
Yang
Amy
A
Childs
Emma
E
Palmer
Abraham A
AA
de Wit
Harriet
H
D001007:Anxiety / Q000139:chemically induced* / Q000235:genetics; D002110:Caffeine / Q000009:adverse effects* / Q000378:metabolism; D000697:Central Nervous System Stimulants / Q000009:adverse effects* / Q000378:metabolism; D003069:Coffee / Q000009:adverse effects; D004327:Drinking Behavior; D005247:Feeding Behavior; D020022:Genetic Predisposition to Disease; D006801:Humans; D010641:Phenotype; D020641:Polymorphism, Single Nucleotide; D043682:Receptor, Adenosine A1 / Q000235:genetics*; D043705:Receptor, Adenosine A2A / Q000235:genetics*
D000697:Central Nervous System Stimulants; D003069:Coffee; D043682:Receptor, Adenosine A1; D043705:Receptor, Adenosine A2A; D002110:Caffeine
Neuropsychopharmacology. 2003 Sep;28(9):1694-702
12825092
Neuropsychopharmacology. 2008 Nov;33(12):2791-800
18305461
Am J Clin Nutr. 2007 Jul;86(1):240-4
17616786
Neuropsychopharmacology. 2010 Aug;35(9):1973-83
20520601
Psychopharmacology (Berl). 2010 Aug;211(3):245-57
20532872